San Francisco, United States
Alife is a pioneering company founded in 2020, dedicated to revolutionizing the in-vitro fertilization (IVF) industry through the integration of artificial intelligence. With its slogan, "Building tools to improve the equity and efficacy of IVF through artificial intelligence," the company aims to create a modern operating system for IVF, enhancing its effectiveness and accessibility.
Operating at the intersection of AI, Health Care, and Machine Learning, Alife addresses critical needs in reproductive medicine from its headquarters in the United States. While specific details of past funding rounds are not available, the company's focus on cutting-edge technology and specialized healthcare solutions makes it an attractive consideration for venture capitalists seeking to invest in transformative health tech innovations.